SARS-CoV-2 vaccine breakthrough by Omicron and Delta variants: comparative assessments with New York State genomic surveillance data
View ORCID ProfileAlexander C. Keyel, View ORCID ProfileAlexis Russell, View ORCID ProfileJonathan Plitnick, View ORCID ProfileJemma V. Rowlands, Eli Rosenberg, View ORCID ProfileDaryl M. Lamson, Kathleen A. McDonough, View ORCID ProfileKirsten St. George
doi: https://doi.org/10.1101/2022.06.24.22276709
Alexander C. Keyel
1Wadsworth Center, New York State Department of Health, Albany, NY, United States of America
Alexis Russell
1Wadsworth Center, New York State Department of Health, Albany, NY, United States of America
Jonathan Plitnick
1Wadsworth Center, New York State Department of Health, Albany, NY, United States of America
Jemma V. Rowlands
2Department of Epidemiology, New York State Department of Health, Albany, NY, United States of America
Eli Rosenberg
2Department of Epidemiology, New York State Department of Health, Albany, NY, United States of America
3Department of Biomedical Science, University at Albany School of Public Health, State University of New York, Albany, NY, United States of America
Daryl M. Lamson
1Wadsworth Center, New York State Department of Health, Albany, NY, United States of America
Kathleen A. McDonough
1Wadsworth Center, New York State Department of Health, Albany, NY, United States of America
2Department of Epidemiology, New York State Department of Health, Albany, NY, United States of America
3Department of Biomedical Science, University at Albany School of Public Health, State University of New York, Albany, NY, United States of America
Kirsten St. George
1Wadsworth Center, New York State Department of Health, Albany, NY, United States of America
3Department of Biomedical Science, University at Albany School of Public Health, State University of New York, Albany, NY, United States of America
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted June 26, 2022.
SARS-CoV-2 vaccine breakthrough by Omicron and Delta variants: comparative assessments with New York State genomic surveillance data
Alexander C. Keyel, Alexis Russell, Jonathan Plitnick, Jemma V. Rowlands, Eli Rosenberg, Daryl M. Lamson, Kathleen A. McDonough, Kirsten St. George
medRxiv 2022.06.24.22276709; doi: https://doi.org/10.1101/2022.06.24.22276709
SARS-CoV-2 vaccine breakthrough by Omicron and Delta variants: comparative assessments with New York State genomic surveillance data
Alexander C. Keyel, Alexis Russell, Jonathan Plitnick, Jemma V. Rowlands, Eli Rosenberg, Daryl M. Lamson, Kathleen A. McDonough, Kirsten St. George
medRxiv 2022.06.24.22276709; doi: https://doi.org/10.1101/2022.06.24.22276709
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (671)
- Anesthesia (181)
- Cardiovascular Medicine (2657)
- Dermatology (224)
- Emergency Medicine (401)
- Epidemiology (12254)
- Forensic Medicine (10)
- Gastroenterology (765)
- Genetic and Genomic Medicine (4116)
- Geriatric Medicine (387)
- Health Economics (681)
- Health Informatics (2666)
- Health Policy (1007)
- Hematology (364)
- HIV/AIDS (854)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (440)
- Neurology (3899)
- Nursing (210)
- Nutrition (579)
- Oncology (2038)
- Ophthalmology (586)
- Orthopedics (242)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (452)
- Public and Global Health (6542)
- Radiology and Imaging (1407)
- Respiratory Medicine (871)
- Rheumatology (411)
- Sports Medicine (343)
- Surgery (452)
- Toxicology (54)
- Transplantation (185)
- Urology (166)